@apertabio.com
Aperta Biosciences is develops safe and effective therapeutics for chronic inflammatory ophthalmic diseases
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Aperta Biosciences is an emerging biopharma company focused on developing novel therapeutics for Ocular Surface Disease (OSD), specifically blepharitis and other related conditions. With a team of experienced executives and specialists in ophthalmic indications, Aperta Biosciences is dedicated to bringing effective treatments to those suffering from OSD. Blepharitis, a common and uncomfortable condition, is characterized by inflammation of the eyelid margins.
If left untreated, it can lead to severe infection, vision impairment, and even permanent alterations to the eyelid. Aperta Biosciences recognizes the role of Demodex mites in blepharitis, as uncontrolled infestations of these mites drive the disease progression. By directly targeting and eliminating Demodex infestations, Aperta Biosciences aims to address the underlying cause of blepharitis.
Aperta Biosciences' lead program, APT-001, is a patent-pending ophthalmic suspension that represents a new treatment approach to blepharitis. This innovative solution directly eradicates ocular demodicosis, providing relief and long-term improvement for those suffering from blepharitis. Trust in Aperta Biosciences to deliver pioneering therapies that offer a clear vision for a healthier ocular surface
Company Type
Privately Held
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories